Table 1 Baseline characteristics of patients using pregabalin
From: Persistence of pregabalin treatment in Taiwan: a nation-wide population-based study
| Â | Number (percentage) |
|---|---|
No. of patients | 114,437 |
Male | 48,316 (42.2) |
Age, mean (SD), year | 60.66 (15.4) |
Monthly income NT$ | |
NT 0–21,009 | 36,963 (32.3) |
NT 210,10-36,825 | 52,546 (45.9) |
> 36,825 | 24,928 (21.8) |
Region of Taiwan | |
Northern region | 49,791 (43.5) |
Central region | 33,899 (29.6) |
Southern region | 27,122 (23.7) |
Eastern region | 3625 (3.2) |
Charlson Comorbidity Index score | |
0 | 39,922 (34.9) |
1 | 26,902 (23.5) |
2–4 | 34,764 (30.4) |
> 4 | 12,849 (11.2) |
Specialties | |
Neurology | 53,910 (47.1) |
Anesthesiology | 5541 (4.8) |
Physiatry | 3151 (2.8) |
Psychiatry | 430 (0.4) |
Rheumatology | 9201 (8.0) |
Others | 42,204 (36.9) |
Indications | |
Herpes zoster | 34,919 (30.5) |
Diabetic peripheral neuropathic pain | 13,369 (11.7) |
Fibromyalgia | 21,051 (18.4) |
Epilepsy | 3301 (2.9) |
Other musculoskeletal diseases | 24,227 (21.2) |
Others | 17,570 (15.4) |
Concomitant medications | |
Gabapentin | 14,114 (12.3) |
Duloxetine | 4410 (3.9) |
NSAIDs | 68,679 (60) |
Acetaminophen | 45,834 (40.1) |
Tramadol | 5011 (4.4) |
Acetaminophen/tramadol | 31,777 (27.8) |
Lidocaine medicated plaster | 1114 (1.0) |
Anti-viral agentsa | 6625 (5.8) |
Daily dosage | |
< 75 mg | 1162 (1.0) |
75-149 mg | 57,106 (49.9) |
150-224 mg | 50,925 (44.5) |
> =225 mg | 5244 (4.6) |